MedTrace Logo

Melatonin Degradation Rate in Human Milk

NCT03591341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-02-01

No results posted yet for this study

Summary

Our long term hypothesis is that giving premature infants breast milk that was pumped during the night and has high concentration of melatonin will improve outcome of several clinical conditions related to premature infants. Prior to testing this, we need to learn the pharmacokinetics of melatonin in vitro.

In this preliminary research we would like to check the levels of melatonin in breast milk pumped during the night, and evaluate the rate of degradation of the melatonin to determine the half life of melatonin in pumped breast milk (in vitro).

Conditions

  • Preterm Infant
  • Lactation

Interventions

DIAGNOSTIC_TEST

melatonin level in pumped breast milk

diagnostic test of melatonin level in pumped breast milk

Sponsors & Collaborators

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • michal molad, MD · Carmel Medical Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-11-30
Completion
2018-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03591341 on ClinicalTrials.gov